The stated reason for the layoff is the CRL for CHRS' Neulasta FoB (#msg-132094293, #msg-132098831), but the delay in submitting the BLA for CHRS' Humira FoB (#msg-132511112) surely has something to do with it too.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.